Acknowledgements
ONCOLOGY
We thank the patients for their participation. We appreciate and acknowledge the helpful contributions made by Evalien Veldhuijzen, Chermaine Noortman-van Meteren, and the research nurses and specialized nurses of the participating hospitals.The funder had no role in the design of the study; the collection, analysis, or interpretation of the data; or the writing of the manuscript and decision to submit it for publication. The results of the study have been presented in part elsewhere at: European Society for Medical Oncology (ESMO) Conference September 2022, Paris France